Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System

PTEN expression is lost in many cancers, and even small changes in PTEN activity affect susceptibility and prognosis in a range of highly aggressive malignancies, such as melanoma and triple-negative breast cancer (TNBC). Loss of PTEN expression occurs via multiple mechanisms, including mutation, tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Moses, Colette, Nugent, Fiona, Waryah, Charlene Babra, Garcia-Bloj, Benjamin, Harvey, Alan R., Blancafort, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348769/
https://www.ncbi.nlm.nih.gov/pubmed/30654190
http://dx.doi.org/10.1016/j.omtn.2018.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348769/
https://www.ncbi.nlm.nih.gov/pubmed/30654190
http://dx.doi.org/10.1016/j.omtn.2018.12.003

Ejemplares similares